Price
$189.00
CJC-1295 5mg / Ipamorelin 5mg — Research Compound
CJC-1295 (a long-acting GHRH analog) and Ipamorelin (a selective ghrelin/GHSR agonist) are commonly referenced in endocrinology research for evaluating growth-hormone axis signaling and downstream biomarkers such as IGF-1 in controlled study settings.
What does that mean in plain English?
In research, this pairing is typically used to study how two different pathways can influence natural GH release patterns—one that mimics upstream “release hormone” signaling (CJC-1295) and one that activates the ghrelin receptor pathway (Ipamorelin). Outcomes in the literature often include GH/IGF-1 measurements and other endocrine markers under protocol conditions.
Specifications:
For Research Use Only (RUO).
Not for human or veterinary use. Not for diagnosis, treatment, cure, or prevention of any disease. Not a food or drug. Not for injection, ingestion, or personal use. Use only by qualified professionals in a controlled laboratory setting.
You must be 21 years old or older in order to access our website. Please verify your age.
Our products are crafted for research and/or investigative purposes and are not suitable for direct human consumption or consumers, nor are they intended for clinical or therapeutic use. The statements and products listed on this website are not intended to diagnose, treat, cure, or prevent any disease.
